Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers

Background: Currently approved vaccines are highly effective in protecting against hospitalization and severe COVID-19 infections. How pre-existing immunity responds to new variants with mutated antigens is crucial information for elucidating the functional interplay between antibodies and B and T cell responses during infection with new SARS-CoV-2 variants. Methods: In this study, we monitored the dynamics and persistence of the immune response versus different SARS-CoV-2 variants of concern that emerged during the pandemic period (2021–2022) in a cohort of vaccinated healthcare workers, who experienced breakthrough infection in the Pre-Delta, Delta, and Omicron waves. We evaluated both the humoral and cell-mediated responses after infection. We also evaluated the anti-SARS-CoV-2 antibodies levels produced by infection in comparison with those produced after vaccination. Results: Our results highlighted that the immune response against the Delta VOC mainly involved an adaptive humoral and switched memory B cells component, even 3 months after the last vaccine dose, conversely showing a high percentage of depleted adaptive T cells. Omicron infections triggered a consistent production of non-vaccine-associated anti-N antibodies, probably to balance the spike epitope immune escape mechanisms. Conclusion: Our results suggest a direct dependence between the VOC and different humoral and B and T cell balances in the post-infection period, despite the administration of a different number of vaccine doses and the elapsed time since the last vaccination..

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Vaccines - 12(2024), 3, p 230

Sprache:

Englisch

Beteiligte Personen:

Sara Caldrer [VerfasserIn]
Silvia Accordini [VerfasserIn]
Cristina Mazzi [VerfasserIn]
Natalia Tiberti [VerfasserIn]
Michela Deiana [VerfasserIn]
Andrea Matucci [VerfasserIn]
Eleonora Rizzi [VerfasserIn]
Stefano Tais [VerfasserIn]
Fabio Filippo [VerfasserIn]
Matteo Verzè [VerfasserIn]
Paolo Cattaneo [VerfasserIn]
Gian Paolo Chiecchi [VerfasserIn]
Concetta Castilletti [VerfasserIn]
Massimo Delledonne [VerfasserIn]
Federico Gobbi [VerfasserIn]
Chiara Piubelli [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.mdpi.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

Cell-mediated immunity
HCWs
Humoral immunity
Medicine
R
SARS-CoV-2 VOCs
Vaccine

doi:

10.3390/vaccines12030230

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ099806479